New! Technothrombin® TGA (Thrombin Generation Assay)

FOR IMMEDIATE RELEASE:

New! Technothrombin® TGA (Thrombin Generation Assay)

West Chester, OH, March 27, 2006 — DiaPharma introduces the Technothrombin® TGA kit, a global research test for investigation of bleeding and thrombotic tendency. This thrombin generation assay from Technoclone is based on monitoring the formation of thrombin with a fluorogenic substrate upon activation of the coagulation cascade by tissue factor (TF).

By providing varying amounts of TF and phospholipid, the Technothrombin® TGA is a universal tool for use in studying hemophilia during inhibitor bypassing therapy, pro-coagulant microparticles, anticoagulant drugs, and thrombophilia. The test can be performed with plasma or whole blood, in platelet rich plasma or platelet poor plasma.

The Technothrombin® TGA is a reliable global coagulation test suitable for investigating subjects for bleeding and thrombotic tendencies.

For more than 8 years, DiaPharma Group, Inc. has sold quality coagulation products to research, clinical and specialty testing laboratories. Today, the company continues to provide gold standard service and a full line of hemostasis products.

Contact DiaPharma at (800) 526-5224 or info@diapharma.com, or visit www.diapharma.com for additional information.

# # #

Contact Information

Jennifer Kiblinger

Technical & Regulatory Affairs Manager

DiaPharma Group, Inc.

Contact via E-mail